John Theurer Cancer Center

Hackensak, New Jersey 07601

0 studies enrolling now · 1 studies all time

What they study most

MDS, Myelodysplastic Syndrome

Studies at this site

• Phase 2 Study Adding Pracinostat to a Hypomethylating Agent (HMA) in Patients With MDS Who Failed to Respond to Single Agent HMA — Completed